Annual Drug Patent Expirations for CRIXIVAN
Crixivan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has forty-one patent family members in thirty-five countries.
The generic ingredient in CRIXIVAN is indinavir sulfate. One supplier is listed for this compound. Additional details are available on the indinavir sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com